You are here: Industry Insights > Vaccine

News List

Experts considering scientific evidence on need for booster dose against COVID expresspharma
December 01, 2021
The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence for the need and justification for booster dose, Rajya Sabha...
Emergex T-Cell Priming COVID Vax Candidate Holds Potential Against Omicron prnasia
December 01, 2021
Emergex Vaccines Holding Ltd., a company tackling major global infectious disease threats through the development of 100% synthetic T- Cell priming vaccines, confirmed that its Vaccine candidate for SARS-CoV-2...
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants prnasia
December 01, 2021
Today EpiVax, Inc. ("EpiVax") confirmed that the company's EPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT")...
HPV Vaccine Is Reducing Cervical Cancers in Teens, Young Women Drugs
December 01, 2021
The first wave of girls to receive the HPV vaccine are much less likely to contract or die from cervical cancer than women just a few years older, a new study reports.
Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Founder Says FirstWordPharma
December 01, 2021
Several scientists said the new Omicron strain of SARS-CoV-2 could lead to more infections among vaccinated people, but some suggested there were reasons to believe the shots would protect against severe disease...
Omicron variant minimally impacts Gritstone’s Covid-19 vaccines Pharmaceutical-Technology
December 01, 2021
Gritstone bio has reported that the mutations seen within the Omicron (B.1.1.529) variant of the SARS-CoV-2 virus does not affect the viruses’ T cell epitopes (TCEs) delivered along with its self-amplifying...
GreenLight Biosciences, Samsung Biologics Partner to Advance New RNA Covid Vax ContractPharma
November 30, 2021
GreenLight Biosciences, a Biotechnology company dedicated to making ribonucleic acid ( RNA ) products affordable and accessible for human health and agriculture, and Samsung Biologics...
Valneva, IDT Biologika Enter COVID Vax Mfg. Pact ContractPharma
November 30, 2021
Valneva SE, a specialty Vaccine company, and IDT Biologika have entered a collaboration for the production of Valneva’s inactivated COVID-19 vaccine candidate VLA2001. This follows last week’s announcement...
Dr Reddy’s eyes Sputnik vaccine exports after domestic struggle ExpressPharma
November 30, 2021
Dr Reddy’s Laboratories is in talks with partners to export domestically-made doses of Russia’s COVID-19 vaccine, Sputnik, after New Delhi recently approved shipments of other shots, the firm said yesterday.
Vaccine Makers Already Testing Their Shots Against Omicron Variant Drugs
November 30, 2021
As concerns about the new omicron variant grow, vaccine makers say they are already working on ways to protect people against the potential new threat.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page